Genetic disposition to addictive disorders - Current knowledge and future perspectives

Current Opinion in Pharmacology

Volumn 5, Issue 1, 2005, Pages 4-8

  Mayer, Peter ^a   Höllt, Volker ^b  

^a FEDERAL INSTITUTE FOR DRUGS AND MEDICAL DEVICES   (Germany)

^b OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR; ALCOHOL; ALCOHOL DEHYDROGENASE; ALDEHYDE DEHYDROGENASE ISOENZYME 2; AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME A; CANNABINOID; CATECHOL METHYLTRANSFERASE; DELTA OPIATE RECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE 4 RECEPTOR; DOPAMINE BETA MONOOXYGENASE; DOPAMINE TRANSPORTER; FATTY ACID AMIDASE; KAPPA OPIATE RECEPTOR; MU OPIATE RECEPTOR; NALOXONE; NICOTINE; OPIATE; PRODYNORPHIN; PROENKEPHALIN; SEROTONIN 1B RECEPTOR; SEROTONIN RECEPTOR; TRYPTOPHAN HYDROXYLASE;

ADDICTION; ALLELE; AUTOMATION; CHROMOSOME MAP; DISEASE ASSOCIATION; GENE CONTROL; GENE EXPRESSION; GENE IDENTIFICATION; GENE INTERACTION; GENE LOCUS; GENE SEQUENCE; GENETIC MARKER; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENOME ANALYSIS; GENOTYPE; HUMAN; LINKAGE ANALYSIS; MEDICAL RESEARCH; MULTIGENE FAMILY; PHENOTYPE; PRIORITY JOURNAL; REVIEW;

ANIMALS; GENOME, HUMAN; GENOTYPE; HUMANS; POLYMORPHISM, SINGLE NUCLEOTIDE; QUANTITATIVE TRAIT LOCI; SUBSTANCE-RELATED DISORDERS;

EID: 12344277671     PISSN: 14714892     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.coph.2004.08.009     Document Type: Review

References (41)

1. A.C. Heath K.K. Bucholz P.A.F. Madden S.H. Dinwiddie W.S. Slutske D.J. Statham M.P. Dunne J. Whitfield N.G. Martin Genetic and environmental contributions to alcohol dependence risk in a national twin sample: consistency of findings in women and men Psychol Med 27 1997 1381-1396
2. T. Reich H.J. Edenberg A. Goate J.T. Williams R.P. Rice P. Van Eerdewegh T. Foroud V. Hesselbrock M.A. Schuckit K. Bucholz K. Carr C. Crose C. Willig H. Begleiter et al. A genome-wide search for genes affecting the risk of alcohol dependence Am J Med Genet 81 1998 207-215
3. T. Foroud H.J. Edenberg A. Goate J. Rice L. Flury D.L. Koller L.J. Bierut P.M. Conneally J.I. Nurnberger K. Bucholz et al. Alcoholism susceptibility loci: Confirmation studies in a replicate sample and further mapping Alcohol Clin Exp Res 24 2000 933-945
4. J. Lappalainen H.R. Kranzler I. Petrakis L.K. Somberg G. Page J.H. Krystal J. Gelernter Confirmation and fine mapping of the chromosome 1 alcohol dependence risk locus Mol Psychiatry 9 2004 312-319
5. W.H. Berrettini T.N. Ferraro R.C. Alexander A.M. Buchberg W.H. Vogel Quantitative trait loci mapping of three loci controlling morphine preference using inbred mouse strains Nat Genet 7 1994 54-58
6. J.C. Crabbe T.J. Phillips K.J. Buck C.L. Cunningham J.K. Belknap Identifying genes for alcohol and drug sensitivity: Recent progress and future directions Trends Neurosci 22 1999 173-179
7. K.E. Marshall E.L. Godden F. Yang S. Burgers K.J. Buck J.M. Sikela In silico discovery of gene-coding variants in murine quantitative trait loci using strain-specific genome sequence databases Genome Biology 3 2002 research0078.1-0078.9
8. M.A. Ehringer J. Thompson O. Conroy D. Goldman T.L. Smith M.A. Schuchit J.M. Sikela Human alcoholism studies of genes identified through mouse quantitative trait locus analysis Addict Biol 7 2002 365-371
9. M.A. Enoch Pharmacogenomics of alcohol response and addiction Am J Pharmacogenomics 3 2003 217-232
10. M.J. Kreek D.A. Nielsen K.S. LaForge Genes associated with addiction: alcoholism, opiate, and cocaine addiction Neuromolecular Med 5 2004 85-108
11. P. Mayer V. Höllt Allelic and somatic variations in the endogenous opioid system of humans Pharmacol Ther 91 2001 167-177
12. A. Becker G. Grecksch R. Brödemann J. Kraus B. Peters H. Schröder W. Thiemann H.H. Loh V. Höllt Morphine self-administration in mu-opioid receptor-deficient mice Naunyn Schmiedebergs Arch Pharmacol 361 2000 584-589
13. A. Becker G. Grecksch J. Kraus H.H. Loh H. Schröder V. Höllt Rewarding effects of ethanol and cocaine in mu opioid receptor-deficient mice Naunyn Schmiedebergs Arch Pharmacol 365 2002 296-302
14. M.R. Hoehe K. Kopke B. Wendel K. Rohde C. Flachmeier K.K. Kidd W.H. Berrettini G.M. Church Sequence variability and candidate gene analysis in complex disease: Association of mu opioid receptor gene variation with substance dependence Hum Mol Genet 9 2000 2895-2908
15. J. Gelernter H. Kranzler J. Cubells Genetics of two mu opioid receptor gene (OPRM1) exon I polymorphisms: Population studies, and allele frequencies in alcohol- and drug-dependent subjects Mol Psychiatry 4 1999 476-483
16. P.F. Sullivan L.J. Eaves K.S. Kendler M.C. Neale Genetic case-control association studies in neuropsychiatry Arch Gen Psychiatry 58 2001 1015-1024
17. C. Bond K.S. LaForge M. Tian D. Melia S. Zhang L. Borg J. Gong J. Schluger J.A. Strong S.M. Leal et al. Single-nucleotide polymorphism in the human mu opioid receptor gene alters beta-endorphin binding and activity: Possible implications for opiate addiction Proc Natl Acad Sci USA 95 1998 9608-9613
18. K. Befort D. Filliol F.M. Decaillot C. Gaveriaux-Ruff M. Hoehe B.L. Kieffer A single nucleotide polymorphic mutation in the human μ-opioid receptor severely impairs receptor signaling J Biol Chem 276 2001 3130-3137
19. A. Beyer T. Koch H. Schröder S. Schulz V. Höllt Effect of the A118G polymorphism on binding affinity, potency and agonist-mediated endocytosis, desensitization, and resensitization of the human mu-opioid receptor J Neurochem 89 2004 553-560
20. C. Skarke J. Darimont H. Schmidt G. Geisslinger J. Lötsch Analgesic effects of morphine and morphine-6-glucuronide in a transcutaneous electrical pain model in healthy volunteers Clin Pharmacol Ther 73 2003 107-121
21. A. Goldstein Addiction: From Biology to Drug Policy 1994 W.H. Freeman and Company New York
22. S.B. Gabriel S.F. Schaffner H. Nguyen J.M. Moore J. Roy B. Blumenstiel J. Higgins M. DeFelice A. Lochner M. Faggart et al. The structure of haplotype blocks in the human genome Science 296 2002 2225-2229
23. K. Xu D. Lichtermann R.H. Lipsky P. Franke X. Liu Y. Hu L. Cao S.G. Schwab D.B. Wildenauer C.H. Bau et al. Association of specific haplotypes of D2 dopamine receptor gene with vulnerability to heroin dependence in 2 distinct populations Arch Gen Psychiatry 61 2004 597-606
24. F.A. Middleton M.T. Pato K.L. Gentile C.P. Morley X. Zhao A.F. Eisener A. Brown T.L. Petryshen A.N. Kirby H. Medeiros et al. Genomewide linkage analysis of bipolar disorder by use of a high-density single-nucleotide-polymorphism (SNP) genotyping assay: A comparison with microsatellite marker assays and finding of significant linkage to chromosome 6q22 Am J Hum Genet 74 2004 886-897
25. G.R. Uhl Q.R. Liu D. Walther J. Hess D. Naiman Polysubstance abuse-vulnerability genes: Genome scans for association, using 1,004 subjects and 1,494 single-nucleotide polymorphisms Am J Hum Genet 69 2001 1290-1300
26. T. Li X. Liu Z.H. Zhu J.H. Zhao X. Hu P.C. Sham D.A. Collier Association analysis of polymorphisms in the μ opioid gene and heroin abuse in the chinese subjects Addict Biol 5 2000 181-186
27. C.Y. Szeto N.L. Tang D.T. Lee A. Stadlin Association between mu opioid receptor gene polymorphisms and Chinese heroin addicts Neuroreport 12 2001 1103-1106
28. P. Franke T. Wang M.M. Nöthen M. Knapp H. Neidt S. Albrecht E. Jahnes P. Propping W. Maier Nonreplication of association between mu-opioid-receptor gene (OPRM1) A118G polymorphism and substance dependence Am J Med Genet 105 2001 114-119
29. J. Shi L. Hui Y. Xu F. Wang W. Huang G. Hu Sequence variations in the mu-opioid receptor gene (OPRM1) associated with human addiction to heroin Hum Mutat 19 2002 459-460
30. J.J. Crowley D.W. Oslin A.A. Patkar E. Gottheil P.A. DeMaria Jr. C.P. O'Brien W.H. Berrettini D.E. Grice A genetic association study of the mu opioid receptor and severe opioid dependence Psychiatr Genet 13 2003 169-173
31. P. Compton D.H. Geschwind M. Alarcon Association between human mu-opioid receptor gene polymorphism, pain tolerance, and opioid addiction Am J Med Genet 121B 2003 76-82
32. E.C. Tan C.H. Tan U. Karupathivan E.P. Yap Mu opioid receptor gene polymorphisms and heroin dependence in Asian populations Neuroreport 14 2003 569-572
33. G. Bart M. Heilig K.S. LaForge L. Pollak S.M. Leal J. Ott M.J. Kreek Substantial attributable risk related to a functional mu-opioid receptor gene polymorphism in association with heroin addiction in central Sweden Mol Psychiatry 9 2004 547-549
34. A.W. Bergen J. Kokoszka R. Peterson J.C. Long M. Virkkunen M. Linnoila D. Goldman Mu opioid receptor gene variants: Lack of association with alcohol dependence Mol Psychiatry 2 1997 490-494
35. T. Sander N. Gscheidel B. Wendel J. Samochowiec M. Smolka H. Rommelspacher L.G. Schmidt M.R. Hoehe Human mu-opioid receptor variation and alcohol dependence Alcohol Clin Exp Res 22 1998 2108-2110
36. T. Town L. Abdullah F. Crawford J. Schinka P.I. Ordorica E. Francis P. Hughes R. Duara M. Mullan Association of a functional mu-opioid receptor allele (+118A) with alcohol dependency Am J Med Genet 88 1999 458-461
37. N. Gscheidel T. Sander B. Wendel P. Heere L.G. Schmidt H. Rommelspacher M.R. Hoehe J. Samochowiec Five exon 1 variants of mu opioid receptor and vulnerability to alcohol dependence Pol J Pharmacol 52 2000 27-31
38. J.A. Schinka T. Town L. Abdullah F.C. Crawford P.I. Ordorica E. Francis P. Hughes A.B. Graves J.A. Mortimer M. Mullan A functional polymorphism within the mu-opioid receptor gene and risk for abuse of alcohol and other substances Mol Psychiatry 7 2002 224-228
39. H. Rommelspacher M. Smolka L.G. Schmidt J. Samochowiec M.R. Hoehe Genetic analysis of the mu-opioid receptor in alcohol-dependent individuals Alcohol 24 2001 129-135
40. D.W. Oslin W. Berrettini H.R. Kranzler H. Pettinati J. Gelernter J.R. Volpicelli C.P. O'Brien A functional polymorphism of the mu-opioid receptor gene is associated with naltrexone response in alcohol-dependent patients Neuropsychopharmacology 28 2003 1546-1552
41. C. Lerman E.P. Wileyto F. Patterson M. Rukstalis J. Audrain-McGovern S. Restine P.G. Shields V. Kaufmann D. Redden N. Benowitz W.H. Berrettini The functional mu opioid receptor (OPRM1) Asn40Asp variant predicts short-term response to nicotine replacement therapy in a clinical trial Pharmacogenomics J 4 2004 184-192